Loading...
PLANETPHARMA — Cefixime Import Profile: Suppliers, Formulations & Sources
Loading...
Pharmaceutical Importer · #9 buyer for Cefixime · $2.8M import value · 88 shipments · FRANCE · DGFT Verified
PLANETPHARMA is the #9 importer of Cefixime from India with $2.8M in import value and 88 verified shipments. PLANETPHARMA holds a 1.3% market share in Cefixime imports based in FRANCE. The company sources from 8 verified suppliers across 51 formulations shipped to 1 country. Overall, PLANETPHARMA imports 5 pharmaceutical products worth $8.2M across 3 therapeutic categories.
Verified from 88 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| MACLEODS PHARMACEUTICALS LIMITED | $1.6M | 47 | 55.0% |
| AMANYS PHARMA INDIA PRIVATE LIMITED | $872.4K | 25 | 30.8% |
| RENA EXPORTS PRIVATE LIMITED | $111.3K | 8 | 3.9% |
| SAHAM PHARMA INDIA PRIVATE LIMITED | $100.0K | 2 | 3.5% |
| IPCA LABORATORIES LIMITED | $85.5K | 2 | 3.0% |
| GALPHA LABORATORIES LIMITED | $50.0K | 1 | 1.8% |
| LINCOLN PHARMACEUTICALS LIMITED | $49.5K | 1 | 1.7% |
| SONVO LIFE SCIENCES | $6.2K | 2 | 0.2% |
PLANETPHARMA sources Cefixime from 8 verified Indian suppliers based on 88 customs records. The primary supplier is MACLEODS PHARMACEUTICALS LIMITED accounting for 55.0% of imports.
Buyers ranked immediately above and below #9 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 8 | PLANET PHARMA | FRANCE | $2.6M | 175 | $14.7K |
| 1 | SAAM GROUP LTD | AFGHANISTAN | $2.4M | 48 | $50.0K |
| 9 | PLANETPHARMA ★ | FRANCE | $2.3M | 46 | $49.1K |
| 10 | MYLAN IRELAND LIMITED, | FRANCE | $1.8M | 54 |
Destination countries from 88 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| FRANCE | $2.8M | 88 | 100.0% |
PLANETPHARMA imports Cefixime to 1 country. The primary destination is FRANCE receiving 100.0% of shipments worth $2.8M.
| Formulation | Value | Shipments |
|---|---|---|
| CEFOLAC 200MG CPR PELL B/8 (CEFIXIME TAB | $285.9K | 6 |
| CEFIXIME SUSPENSION 100MG(CEFOLAC DRY SYRUP 100MG / 5ML) 1X1 | $155.1K | 4 |
| CEFIXIME SP 200 CEFIXIME 200MGTABS PACK | $150.0K | 3 |
| CEFIXIME SP 200 CEFIXIME 200MGTABS PACKOF 1X10TABS ) ITEM CODE:CEFI121 3000000220702 BATCH NO:SETB23009,SETB23009,SETBNOS | $140.0K | 3 |
| CEFOLAC 200 MG CPR PELL B/8 (CEFIXIME TA | $110.3K | 3 |
| CEFOLAC 200MG CPR PELL B/8 (CEFIXIME TABLET 200MG) CEFO144 2X4S (39360 PAC)TBS | $102.8K | 3 |
| CEFIXIME SP 200 (CEFIXIME 200 MG TABS PACK OF 1X10 TABS) ITEM CODE:CEFI121 3000000220702 BATCH NO: SETB24010 MFG:DEC-24 | $100.0K | 2 |
| CEFIXIME SP 200 (CEFIXIME 200 MG TABS PACK OF 1X10 TABS) ITEM CODE:CEFI121 3000000220702 BATCH NO: SETB24011 MFG:DEC-24 |
India exported $24.0M worth of Cefixime through 8,398 shipments from 668 suppliers to 131 countries, serving 1,805 buyers globally. PLANETPHARMA imports $2.8M of this total, accounting for 1.3% of India's Cefixime exports with 88 shipments from FRANCE. This is verified from 88 customs shipment records covering 51 distinct formulations.
PLANETPHARMA's average Cefixime order value is $32.2K per consignment, based on 88 shipments totaling $2.8M. PLANETPHARMA is based in FRANCE and ranks #9 among all Cefixime importers from India by value. The company sources from 8 verified suppliers in India.
PLANETPHARMA sources Cefixime from 8 verified Indian suppliers: MACLEODS PHARMACEUTICALS LIMITED ($1.6M, 55.0%), AMANYS PHARMA INDIA PRIVATE LIMITED ($872.4K, 30.8%), RENA EXPORTS PRIVATE LIMITED ($111.3K, 3.9%), SAHAM PHARMA INDIA PRIVATE LIMITED ($100.0K, 3.5%), IPCA LABORATORIES LIMITED ($85.5K, 3.0%). This is based on 88 customs records.
PLANETPHARMA ranks #9 among 1,805 Cefixime importers from India with a 1.3% market share. The top 3 importers are AL-KAWKAB SCIENTIFIC BUREAU ($3.7M), PLANET PHARMA ($2.6M), SAAM GROUP LTD ($2.4M). PLANETPHARMA processed 88 shipments from FRANCE.
PLANETPHARMA also imports these advanced antibiotics products. Each links to the detailed product page.
PLANETPHARMA imports 5 products worth $8.2M. Beyond Cefixime, top products include Azithromycin, Ceftriaxone, Domperidone, Ornidazole. View the complete PLANETPHARMA profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Cefixime — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for PLANETPHARMA's Cefixime imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
PLANETPHARMA
Full Company Profile →
5 products · $8.2M total trade · 3 categories
| $33.7K |
| 12 | TO THE DIRECTOR OF | SUDAN | $1.7M | 75 | $22.6K |
PLANETPHARMA ranks #9 among 1,805 Cefixime importers from India. Average shipment value of $49.1K compared to the market average of $13.3K. The closest competitors by value are PLANET PHARMA and SAAM GROUP LTD.
| $100.0K |
| 2 |
| CEFIXIME SP 100 (CEFIXIME FOR ORAL SUSPENSION USP 100MG/5ML) ITEM CODE:CEFI124 3990000000 BATCH NO:SCSB24004 MFG:DEC-24 | $89.2K | 2 |
| CEFOLAC 200MG CPR PELL B/8 (CEFIXIME TABLET 200MG) CEFO144 2X4S (33750 PAC)TBS | $78.4K | 3 |
PLANETPHARMA imports 51 distinct Cefixime formulations from India. The top formulation is CEFOLAC 200MG CPR PELL B/8 (CEFIXIME TAB with 6 shipments worth $285.9K.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 131+ countries, 1,805+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Verified from customs records
Access shipment-level records, supplier contacts, and formulation details for PLANETPHARMA.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Cefixime. For current order-level data, contact TransData Nexus.